Test directory

This fully searchable directory currently lists all commercially available immunoassays and molecular tests for COVID-19 of which FIND is aware. Manufacturer performance data (sensitivity and specificity) are included, where known, alongside data from independent evaluations conducted by FIND, where applicable. We are continuing to build this database, and will be adding other tests (which for the moment are still listed here), as well as data from independent evaluations by other entities. This project is part of our work on the ACT-Accelerator Diagnostics Pillar. If you have any queries on the information included or updates to share on your test(s), please contact us

It has come to our attention that certain companies and websites are claiming to hold certificates endorsed by FIND and referring to the FIND name and logo. Third-party usage of the FIND logo to imply endorsement of services or diagnostic tools is not and has never been, authorized by FIND.

Last updated: 17 January 2022
RETURN TO MAIN SCREEN

Rheonix COVID-19™ MDx Assay

Export this page in pdf
Regulatory status
US FDA EUA
Time to result
5
Assay target
RNA
Test format
NAT reagent kit – proprietary platform
Technology principle
qRT-PCR
Target analyte
N gene
Level of automation
Fully automated (including sample preparation)
Laboratory/Point-of-care
Lab-based
Self-testing/Self-Collection
Intended for professional use only
Validated sample types
Bronchoalveolar lavage
Mid-turbinate swab
Nasal swab
Nasopharyngeal swab
Oropharyngeal swab
Saliva
Connectivity
Yes
IMPACT OF SARS-COV-2 VARIANT:
Alpha - No expected impact (in silico analyses)
Beta - No expected impact (in silico analyses)
Gamma - Unknown
Manufacturer performance data
Sensitivity
0%
Specificity
0%